Live birth with vitrified-warmed oocytes of a chronic myeloid leukemia patient nine years after allogenic bone marrow transplantation

Kim, Mi Kyoung; Lee, Dong Ryul; Han, Ji Eun; Kim, You Shin; Lee, Woo Sik; Won, Hyung Jae; Kim, Ji Won; Yoon, Tae Ki

doi:10.1007/s10815-011-9681-y

Cited by 43 publications

(20 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The technique of ultra-rapid cryopreservation (i.e. vitirification) has shown excellent survival rates (80-95%) Garcia-Velasco et al, 2013;Kim et al, 2011;Parmegiani et al, 2011;Rienzi et al, 2012), and great fertilization and implantation rates (Alpha Scientist in Reproductive Medicine and ESHRE Special Interest Group in Embryology, 2011; Cobo et al, 2013;Garcia-Velasco et al, 2013;Rienzi et al, 2012). We, and others (Cobo and Diaz, 2011;Cobo et al, 2010;Parmegiani et al, 2011) have consistently shown that cryopreservation of oocytes through vitrification is an effective, simple, safe, and efficient technique for fertility preservation in women who are about to start oncological treatments with gonadotoxic impact.…”

Section: Discussionmentioning

confidence: 99%

“…Porcu et al (2008) described one case of twins conceived with warmed oocytes and delivered by a cancer patient after oocyte cryopreservation and bilateral ovariectomy as a result of ovarian cancer. Additionally, Kim et al (2011) described the second case in a patient with chronic myeloid leukaemia who had her eggs vitrified, and gave birth to a biological baby in 2011.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer

Martínez

Rabadán

Domingo

et al. 2014

Reproductive BioMedicine Online

View full text Add to dashboard Cite

Obstetric outcome of first pregnancies achieved after vitrification and warming oocytes from women being treated for cancer was evaluated. Of a total of 493 women who consulted for fertility preservation, 357 had their oocytes cryopreserved after being diagnosed with cancer, and 11 returned after being cured for assisted reproduction treatments (eight had breast cancer, one Hodgkin lymphoma, one endometrial adenocarcinoma, and one thyroid cancer). The oocyte survival rate was 92.3%, the fertilization rate was 76.6%, and the mean number of embryos transferred was 1.8 ± 0.7. Beta-human chorionic gonadotropin was detected in seven out of the 11 embryo transfers carried out. Four ongoing pregnancies were achieved and delivered at term with normal fetal weight and no major or minor malformations. Women diagnosed with cancer who have their eggs cryopreserved before anti-cancer treatment have good assisted reproductive technology performance and good perinatal outcomes. Cryopreservation of oocytes seems to be a good alternative for fertility preservation in these women.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer

Martínez

Rabadán

Domingo

et al. 2014

Reproductive BioMedicine Online

View full text Add to dashboard Cite

show abstract

“…Kim et al [15] reported the first case of a live birth following the use of vitrified-warmed oocytes in a cancer patient. Thus, the use of vitrifiedwarmed oocytes for cancer patients may be a safe technique.…”

Section: Discussionmentioning

confidence: 99%

A live birth from vitrified‐warmed oocytes in a Philadelphia chromosome‐positive acute lymphoid leukemia patient 5 years following allogenic bone marrow transplantation and after a magnitude 9.0 earthquake in Japan

Doshida¹,

Nakajo²,

Toya³

et al. 2013

Reprod Medicine & Biology

View full text Add to dashboard Cite

Purpose To report a live birth from vitrified-warmed oocytes for a Philadelphia chromosome-positive acute lymphoid leukemia (Ph-ALL) patient. Methods A 20-year-old single woman with Ph-ALL requested oocyte cryopreservation at a private fertility clinic using assisted reproduction technology (ART). In cases of leukemia, there is a very short time before chemotherapy, follwed shortly by total body irradiation (TBI), and although she had already received the chemotherapy, ten oocytes were vitrified and stored for 59 months before warming. Soon after the oocyte cryopreservation, she received TBI and bone marrow transplant (BMT). During the storage, a magnitude 9.0 earthquake occurred making oocyte transport necessary. The embryo transfer was planned in a hormone replacement cycle, and intracytoplasmic sperm injection (ICSI) was performed on the vitrified-warmed oocytes. On day 3, two embryos were transferred. Results The patient became pregnant and delivered a healthy girl after ICSI using vitrified-warmed oocytes. Conclusions: Oocyte cryopreservation is the best option for fertility preservation of young single women with leukemia. Oncologists and gynecologists who conduct ART should cooperate to improve the quality of life of cancer patients.

show abstract

“…Both RIC (especially avoiding total body irradiation) and cryopreservation of sperm, oocyte, or gonadal tissue resulted in successful pregnancy in posttransplant survivors with CML. 68,69 Fertility preservation should be discussed before allo-SCT with both pediatric and adult recipients who desire to bear children.…”

Section: Pregnancy In CMLmentioning

confidence: 99%

The role of stem cell transplantation for chronic myelogenous leukemia in the 21st century

Barrett

Ito

2015

Blood

View full text Add to dashboard Cite

The introduction of tyrosine kinase inhibitors (TKIs), a treatment of chronic myelogenous leukemia (CML), has largely replaced curative strategies based on allogeneic stem cell transplantation (SCT). Nevertheless, SCT still remains an option for accelerated/blastic-phase and selected chronic-phase CML. Transplant outcomes can be optimized by peritransplant TKIs, conditioning regimen, BCR-ABL monitoring, and relapse management. Controversies exist in transplant timing, pediatric CML, alternative donors, and economics. SCT continues to serve as a platform of “operational cure” for CML with TKIs and immunotherapies.

show abstract

Live birth with vitrified-warmed oocytes of a chronic myeloid leukemia patient nine years after allogenic bone marrow transplantation

Cited by 43 publications

References 23 publications

Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer

Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer

A live birth from vitrified‐warmed oocytes in a Philadelphia chromosome‐positive acute lymphoid leukemia patient 5 years following allogenic bone marrow transplantation and after a magnitude 9.0 earthquake in Japan

The role of stem cell transplantation for chronic myelogenous leukemia in the 21st century

Contact Info

Product

Resources

About